THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$229,331,844
Other Assets
37%
Property, Plant, & Equipment (net)
29%
Investments
27%
Receivables (Non-Related)
7%
Prepaid Expenses
<1%
Inventories
<1%
Cash & Equivalents
0%
Related-Party Receivables
0%
Liabilities in 2024 (Year End)
$53,331,635
Payables & Accruals
56%
Other Liabilities
44%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$0
$0
-
Receivables (Non-Related)
$17,725,659
$15,849,414
-11%
Related-Party Receivables
$0
$0
-
Inventories
$523
$523
+0%
Prepaid Expenses
$674,607
$572,371
-15%
Investments
$52,637,049
$61,078,430
+16%
Property, Plant, & Equipment (net)
$68,117,109
$67,107,322
-1%
Other Assets
$83,655,681
$84,723,784
+1%
Total Assets
$222,810,628
$229,331,844
+3%
Liabilities
2023
2024
Change
Payables & Accruals
$27,578,354
$29,962,431
+9%
Grants Payable
$0
$0
-
Deferred Revenue
$0
$0
-
Tax-Exempt Bond Liabilities
$0
$0
-
Custodial & Escrow Liabilities
$0
$0
-
Notes Payable / Debt (Non-Related)
$0
$0
-
Related-Party Payables
$0
$0
-
Other Liabilities
$22,439,023
$23,369,204
+4%
Total Liabilities
$50,017,377
$53,331,635
+7%
Net assets
2023
2024
Change
Restricted Net Assets
$160,117,301
$165,058,388
+3%
Unrestricted Net Assets
$12,675,950
$10,941,821
-14%
Net assets
2023
2024
Change
Net assets
+$172,793,251
+$176,000,209
+2%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)